| abstract |
The invention relates to compounds of formula (I) or a stereoisomer, tautomer or pharmaceutically acceptable salt thereof, wherein R, R, R, R, R, R, R, R, R, W, W, Y and n are as defined herein. Also described are pharmaceutically acceptable compositions of the compounds of formula (I), as well as methods for using the compounds of formula (I) and pharmaceutically acceptable compositions of the compounds of formula (I) as Mnk inhibitors, as well as therapeutic agents for treating diseases such as cancer. |